Author

V. S. Raj

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Biophysics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:drug response / drug discovery· 2 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:protein sequence· 1

Frequent Co-Authors

J. Joseph· 2 shared K. Thankamani· 2 shared A. Ajay· 1 shared A. Upadhyaya· 1 shared A. Yadav· 1 shared D. Upadhyay· 1 shared G. Nadig· 1 shared I. Pramanick· 1 shared

Activity by Year

2020-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

J. Joseph

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

A novel fluorobenzothiazole RBx 10080758 as a dual inhibitor against bacterial GyraseB (GyrB) and Topoisomerase IV (parE) of Gram-positive pathogens causing skin and respiratory infections

T. Barman, M. Kumar, T. Chaira, S. Singhal, T. Mathur, V. Kalia, R. Gangadharan, M. Rao, M. Pandya, P. Bhateja, R. Sood, D. Upadhyay, S. Varughese, A. Yadav, L. Sharma, , V. S. Raj

This paper evaluates a novel fluorobenzothiazole inhibitor, RBx 10080758, showing potent in vitro and in vivo activity against drug-resistant Gram-positive bacteria by dual targeting Gyrase B and Topoisomerase IV.

bioRxiv · Sep 8, 2022 · PreprintMicrobiology

Green tea and Spirulina extracts inhibit SARS, MERS, and SARS-2 spike pseudotyped virus entry in vitro

J. Joseph, K. Thankamani, A. Ajay, V. R. A. Das, V. S. Raj

Current Pharmaceutical Biotechnology · Jul 1, 2022Peer-reviewedMicrobiology

Design of a highly thermotolerant, immunogenic SARS-CoV-2 spike fragment

S. K. Malladi, R. Singh, S. Pandey, S. Gayathri, K. Kanjo, S. Ahmed, M. S. Khan, P. Kalita, N. Girish, A. Upadhyaya, P. Reddy, I. Pramanick, M. Bhasin, S. Mani, S. Bhattacharyya, , R. Varadarajan

This paper designs a thermotolerant, immunogenic SARS-CoV-2 RBD protein fragment that is stable at high temperatures and elicits neutralizing antibodies in guinea pigs.

bioRxiv · Aug 15, 2020Biophysics